| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/19/2007 | US7232887 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/19/2007 | US7232882 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin |
| 06/19/2007 | US7232808 Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD) |
| 06/19/2007 | US7232800 for a cleavage reagent while preserving the anti-microbial activity; reagent includes alkaline protease such as trypsin and clotrispain; genetic engineering |
| 06/19/2007 | US7232680 For producing vaccine for protecting a mammal or a bird from infection by a Nidovirales virus |
| 06/19/2007 | US7232678 Identification of oligoadenylate synthetase-like genes |
| 06/19/2007 | US7232676 Chondroitin synthase and nucleic acid encoding the enzyme |
| 06/19/2007 | US7232675 Sulfotransferase, its polypeptide and DNA encoding the same |
| 06/19/2007 | US7232674 Process for producing α1,4-galactosyltransferase and galactose-containing complex sugar |
| 06/19/2007 | US7232672 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 06/19/2007 | US7232664 Preparing and recovering lactic acid for use in cosmetics, foods, drugs and plastics from genetically engineered yeast comprising defect in pyruvate decarboxylase pathway |
| 06/19/2007 | US7232569 Type III secretion pathway in aeromonas salmonicida, and uses therefor |
| 06/19/2007 | US7232563 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
| 06/19/2007 | CA2281830C Methods of commercial production and extraction of protein from seed |
| 06/19/2007 | CA2171292C Oxidation-stable proteases |
| 06/19/2007 | CA2158745C Inhibitor of vascular endothelial cell growth factor |
| 06/19/2007 | CA2073124C Tumor antigen specific antibody |
| 06/19/2007 | CA1341532C Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same |
| 06/15/2007 | CA2569062A1 Recombinant triplex scaffold-based polypeptides |
| 06/14/2007 | WO2007067596A2 Methods and compositions for needleless delivery of antibodies |
| 06/14/2007 | WO2007067046A1 Means and methods for influencing the stability of antibody producing cells |
| 06/14/2007 | WO2007067032A1 Means and methods for influencing the stability of cells |
| 06/14/2007 | WO2007066823A1 Antibody against connective tissue growth factor or composition containing the same |
| 06/14/2007 | WO2007066775A1 TRANSGENIC FOWL HAVING Gla RESIDUE IN PROTEIN DERIVED FROM FOREIGN GENE |
| 06/14/2007 | WO2007066694A1 Method for production of soybean peptide mixture |
| 06/14/2007 | WO2007066627A1 Multi-purpose acylation catalayst and use thereof |
| 06/14/2007 | WO2007066430A1 Process for producing peptide |
| 06/14/2007 | WO2006109192A3 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 06/14/2007 | WO2006104749A3 Compositions and methods for detecting compounds that treat a neurological disorder |
| 06/14/2007 | WO2006010038A3 Inducible fluorescence assay |
| 06/14/2007 | WO2004032847A3 Hepatocyte growth factor variants |
| 06/14/2007 | WO2003012126A3 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 06/14/2007 | US20070136833 Genes encoding several poly (ADP-RIBOSE) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith |
| 06/14/2007 | US20070136832 Novel lipoxygenase proteins and polynucleotides encoding the same |
| 06/14/2007 | US20070136829 Novel type-1 cytokine receptor glm-r |
| 06/14/2007 | US20070136826 Anti-mouse CD20 antibodies and uses thereof |
| 06/14/2007 | US20070136825 Fusion proteins useful for detecting analytes |
| 06/14/2007 | US20070135625 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 06/14/2007 | US20070135621 Therapeutic products with enhance ability to immunomodulate cell functions |
| 06/14/2007 | US20070135620 Fc variants with altered binding to FcRn |
| 06/14/2007 | US20070135347 Heterodimeric soluble receptor for identifying modulators for prevention and treatment of cell proliferative disorders |
| 06/14/2007 | US20070135344 Novel growth factor and a genetic sequence encoding same |
| 06/14/2007 | US20070135340 IGF-1 novel peptides |
| 06/14/2007 | US20070134766 Methods of assessing hiv integrase inhibitor therapy |
| 06/14/2007 | US20070134765 Recombinant bacteria and uses thereof |
| 06/14/2007 | US20070134764 Endogenous and non-endogenous version of human G protein-coupled receptors |
| 06/14/2007 | US20070134763 Anti-virus therapy for respiratory diseases |
| 06/14/2007 | US20070134762 Immunogenic peptide carrier conjugates and methods of producing same |
| 06/14/2007 | US20070134761 Minimal dna sequence acting as a chromatin insulator and its use in protein expression |
| 06/14/2007 | US20070134760 provide alternative host cells comprising multiple copies of a gene of interest, which cells are devoid of antibiotic markers, for use in the industrial production of polypeptides in high yields |
| 06/14/2007 | US20070134759 Process for producing antibody composition by using rna inhibiting the function of alpha1,6-fucosyltransferase |
| 06/14/2007 | US20070134758 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors |
| 06/14/2007 | US20070134757 Method for cleaving proteins |
| 06/14/2007 | US20070134755 Method of producing cell extract for cell-free protein synthesis |
| 06/14/2007 | US20070134752 Smooth muscle myosin phosphatase associated kinase |
| 06/14/2007 | US20070134750 Glucose dehydrogenase |
| 06/14/2007 | US20070134745 Using cytokine receptor-16 expression as evaluative tool in diagnosis of cell proliferative disorders |
| 06/14/2007 | US20070134727 Antibodies to cytokine receptor |
| 06/14/2007 | US20070134717 Oxaloacetate hydrolase deficient fungal host cells |
| 06/14/2007 | US20070134704 Expression vector comprising nucleotide sequences coding fluorescent neurofilament protein (NFP) for diagnostic imaging tool in molecular genetics |
| 06/14/2007 | US20070134703 Chromophores/fluorophores and methods for using the same |
| 06/14/2007 | US20070134680 Lipid metabolism molecules |
| 06/14/2007 | US20070134655 a nucleotide sequence of a first half of said RNA precursor is a partial inversed-reversed sequence of a nucleotide sequence of a second half |
| 06/14/2007 | US20070134263 Grampositive immunogen protein for use in developing vaccine for prevention of microorganismal infection; immunization |
| 06/14/2007 | US20070134257 Metal-binding therapeutic peptides |
| 06/14/2007 | US20070134256 Chimpanzee Fab antibodies against DENV-4; isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith |
| 06/14/2007 | US20070134254 antibodies that immunospecifically bind to tyrosine kinase receptors (EphA2) and competes for binding to EphA2 with the EA5 antibody, used for cancer therapy |
| 06/14/2007 | US20070134253 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas |
| 06/14/2007 | US20070134241 Humanized anti-CD3 specific antibodies |
| 06/14/2007 | US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 06/14/2007 | US20070134237 Human cytokine receptor |
| 06/14/2007 | US20070134236 Humanized antibodies against monocyte chemotactric proteins |
| 06/14/2007 | US20070134234 Immunomodulatory compositions and uses therefor |
| 06/14/2007 | US20070134229 Non-native constitutively active osteopontin |
| 06/14/2007 | US20070134228 Immunoaffinity purification |
| 06/14/2007 | US20070134227 Catalyst for cleaving sugar chain |
| 06/14/2007 | CA2633157A1 Means and methods for influencing the stability of antibody producing cells |
| 06/14/2007 | CA2632662A1 Methods of in vitro propagation and detection of infectious prion |
| 06/14/2007 | CA2632517A1 Methods for cyclic nucleotide determination |
| 06/14/2007 | CA2632419A1 Genetically recombinant anti-perp antibody |
| 06/14/2007 | CA2631952A1 Methods and compositions for needleless delivery of antibodies |
| 06/14/2007 | CA2627444A1 Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
| 06/13/2007 | EP1795598A1 Novel peptides |
| 06/13/2007 | EP1795592A2 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 06/13/2007 | EP1795203A2 Fhit proteins and nucleic acids and methods based thereon |
| 06/13/2007 | EP1794588A2 Methods and compositions for measuring canine bnp and uses thereof |
| 06/13/2007 | EP1794323A2 In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
| 06/13/2007 | EP1794312A2 Site-specific labeling of proteins for nmr studies |
| 06/13/2007 | EP1794298A2 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells |
| 06/13/2007 | EP1794189A1 Ace-inhibitory whey hydrolysates |
| 06/13/2007 | EP1793855A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 06/13/2007 | EP1793812A2 Antibiotic compound |
| 06/13/2007 | EP1572897A4 Ordered biological nanostructures formed from chaperonin polypeptides |
| 06/13/2007 | EP1481245A4 Determination of compatibility of a set of chemical modifications with an amino-acid chain |
| 06/13/2007 | EP1470146B1 Antibodies against the muc18 antigen |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1117804B1 Mutants of op-1 |